Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
X-ray repair cross complementing 6 pseudogene 3 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 1980 | 2019 | |||||||||
|
homeobox A cluster | 0.599 | 0.654 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1992 | 2019 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 | 0.678 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
MAGE family member A3 | 0.588 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.900 | strong | 1.000 | 2 | 0 | 1998 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2002 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2011 | ||||||||
|
solute carrier family 22 member 16 | 0.626 | 0.500 | 6.3E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1999 | 2008 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.100 | None | 0.909 | 1 | 0 | 1996 | 2017 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2006 | 2012 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
arachidonate 15-lipoxygenase | 0.502 | 0.846 | 1.1E-23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.090 | None | 0.889 | 1 | 0 | 2004 | 2019 | ||||||||
|
hyaluronan mediated motility receptor | 0.544 | 0.615 | 5.5E-21 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
NADPH oxidase 4 | 0.471 | 0.885 | 5.8E-20 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2015 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.080 | None | 0.875 | 1 | 0 | 1984 | 2013 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2000 | 2015 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
nibrin | 0.467 | 0.808 | 2.2E-16 |
|
disease | 0.070 | None | 1.000 | 2 | 0 | 1996 | 2013 | ||||||||
|
peptidyl arginine deiminase 4 | 0.494 | 0.808 | 4.6E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
solute carrier family 5 member 8 | 0.615 | 0.577 | 5.0E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 |